Skip to main navigation Skip to search Skip to main content

Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001

  • Caroline E. McCoach
  • , Christian Rolfo
  • , Alexander Drilon
  • , Mario Lacouture
  • , Benjamin Besse
  • , Koichi Goto
  • , Viola W. Zhu
  • , Daniel S.W. Tan
  • , Stephanie Farajian
  • , Laura A. Potter
  • , Jennifer F. Kherani
  • , Victoria Soldatenkova
  • , Elizabeth A. Olek
  • , Catherine E. Muehlenbein
  • , Keunchil Park
  • University of California at San Francisco
  • Genentech, Inc
  • University of Maryland School of Medicine
  • Icahn School of Medicine at Mount Sinai
  • Memorial Sloan-Kettering Cancer Center
  • Gustave Roussy
  • National Cancer Center Japan
  • University of California at Irvine
  • Duke-NUS Medical School
  • University of California at Davis
  • Eli Lilly

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry